Apceth

Contact
apceth.com

Apceth GmbH & Co. KG

Rosenheimer Platz 6
81669 München
Germany
apceth.com
Contact
Profile News
Contact

About Apceth

apceth Biopharma has adopted the new name Minaris Regenerative Medicine

Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with more than 20 years' experience providing outstanding quality and reliability. Our facilities in the US, Europe, and Asia allow us to supply patients worldwide with life-changing therapies.

Read more about Apceth
Facts about Apceth
  • Industry : Biotechnology

News about Apceth

Apceth

04-Feb-2019 | business & finance

Hitachi Chemical to acquire apceth Biopharma

apceth Biopharma GmbH announces that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all shares of apceth Biopharma GmbH. This ...

Read news
Apceth

28-Apr-2015 | people

apceth Names Ulrike Verzetnitsch as Chief Technical Office

apceth GmbH & Co. KG is continuing to expand its senior management team and has announced the appointment of Ulrike Verzetnitsch as Chief Technical Officer ...

Read news
Apceth

30-Mar-2015 | research and development

apceth Initiates Phase II Clinical Trial for Engineered Cell Therapy to Treat Gastrointestinal Cancer

apceth announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME ...

Read news
Apceth

10-Sep-2013 | people

apceth Names Dr Stefanos Theoharis Chief Business Officer

apceth GmbH has announced the expansion of its senior management team with the appointment of Dr Stefanos Theoharis as Chief Business Officer.In this newly ...

Read news
Apceth

24-Feb-2012 | business & finance

apceth and Indivumed to Develop Biomarker Platform for Targeted Cellular Therapies

apceth GmbH & Co. KG and Indivumed GmbH have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the ...

Read news
Apceth

04-Nov-2011 | manufacturing

apceth Received Extended Manufacturer's Licence for Somatic Cell Therapeutics At The Ottobrunn Site

Adult stem cell research at the highest level will be possible at the new apceth site in Ottobrunn near Munich, Germany: in August 2011, the Munich biotech ...

Read news
Apceth

12-Oct-2011 | people

apceth is extending its top management

Prof. Ralf Huss moves from Roche to the biotechnology company apceth

Read news
Apceth

24-Aug-2011 | research and development

apceth Starts First Phase I/II Clinical Study on Somatic Cell Therapy for Peripheral Arterial Occlusive Disease

30 patients involved in the study: initial results expected by mid 2012

Read news
Show more news about Apceth

Here you will find Apceth GmbH & Co. KG